CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the link between systemic autoimmune diseases and the risk of developing second breast cancers in female cancer survivors. By analyzing large cohorts and employing advanced genetic and statistical methods, it aims to uncover how autoimmune conditions interact with cancer treatments to influenc…
Approximately 1 in 5 newly diagnosed cancers is a second or subsequent cancer related to treatment for a first cancer.
Second breast cancers (SBCs) are the most commonly diagnosed.
Those who develop SBCs have reduced treatment options and worse outcomes than comparable individuals with first primary breast cancers.
There are over 12 million female cancer survivors in the EU, of whom at least 15% will develop an SBC. A better understanding of the etiology and risk factors for SBC is therefore ess…
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
